Patents by Inventor Hiroaki Kinugasa

Hiroaki Kinugasa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4248883
    Abstract: 1-(3-Mercapto-2-methylpropanoyl)prolyl amino acid derivatives of the formula ##STR1## wherein R represents a hydrogen atom, a lower alkyl group, a phenyl-lower alkyl group or a substituted phenyl-lower alkyl group, R.sub.1 represents a hydrogen atom, R.sub.4 CO--, R.sub.5 S--, or ##STR2## R.sub.2 represents a hydrogen atom or a lower alkyl group, R.sub.3 represents a hydrogen atom, a phenyl group, a lower alkyl group, or a substituted lower alkyl group, or R.sub.2 and R.sub.3 form a heterocyclic ring together with the nitrogen and carbon atoms to which they are respectively bonded; salts of these compounds; compositions comprising these compounds or salts; and processes for preparing these compounds or salts. These compounds and salts have excellent antihypertensive activity.
    Type: Grant
    Filed: June 29, 1979
    Date of Patent: February 3, 1981
    Assignee: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Tadahiro Sawayama, Hiroaki Kinugasa, Haruki Nishimura, Kunihiko Takeyama, Kanoo Hosoki
  • Patent number: 4029780
    Abstract: A compound of the formula ##STR1## wherein R.sub.1 represents a hydrogen atom or a lower alkyl group, and R.sub.2 represents a hydrogen or halogen atom or a trifluoromethyl group,And its pharmaceutically acceptable salt. The compound is prepared by reacting the corresponding 1,2,4-benzothiadiazine 1,1-dioxide with a piperazine compound or alkylating 1,2,4-benzothiadiazine 1,1-dioxide whose corresponding 3-position is substituted by a piperazinyl group. The above compound has superior antihypertensive activity separated from diuretic, antidiuretic and hyperglycemic activities, and is free from side-effects.
    Type: Grant
    Filed: October 28, 1975
    Date of Patent: June 14, 1977
    Assignee: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Haruki Nishimura, Masanao Shimizu, Naonobu Hatano, Katsuyoshi Nakatsuzi, Hiroaki Kinugasa, Hiroko Kon